Fittingly, overexpression of GNL3 was previously shown to reduce the density of mushroom dendritic spines in rats, which might relate to dendritic spine pathology observed across patients with schizophrenia, bipolar disorder, and depression [45]. This evidence concerns the gene GNL3 and major depressive disorder.